Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hielke J Meulenbeld

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|November 7, 2008
Images in clinical medicine. Binocular proptosis in orbital lymphomaHielke J Meulenbeld, Wim Peters
Drugs & Aging|March 17, 2007
First-line treatment strategies for elderly patients with metastatic colorectal cancerHielke J Meulenbeld, Geert-Jan Creemers
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Chemotherapy in patients with castration-resistant prostate cancerHielke J Meulenbeld, Paul Hamberg, Ronald de Wit
Expert Opinion on Investigational Drugs|January 17, 2012
Danusertib, an aurora kinase inhibitorHielke J Meulenbeld, Ron Hj Mathijssen, Jaap Verweij, et al.
International Journal of Cancer|February 13, 2004
Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancerWouter H de Vos tot Nederveen Cappel, Hielke J Meulenbeld, Jan H Kleibeuker, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2013
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)Hielke J Meulenbeld, Johann S de Bono, Scott T Tagawa, et al.
BJU International|August 30, 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failureHielke J Meulenbeld, Jean P Bleuse, Elio M Vinci, et al.
Cancers|August 23, 2019
Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with CabazitaxelIngeborg E de Kruijff, Anieta M Sieuwerts, Wendy Onstenk, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
European Urology|July 20, 2015
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor CellsWendy Onstenk, Anieta M Sieuwerts, Jaco Kraan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|November 7, 2008
Images in clinical medicine. Binocular proptosis in orbital lymphomaHielke J Meulenbeld, Wim Peters
Drugs & Aging|March 17, 2007
First-line treatment strategies for elderly patients with metastatic colorectal cancerHielke J Meulenbeld, Geert-Jan Creemers
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Chemotherapy in patients with castration-resistant prostate cancerHielke J Meulenbeld, Paul Hamberg, Ronald de Wit
Expert Opinion on Investigational Drugs|January 17, 2012
Danusertib, an aurora kinase inhibitorHielke J Meulenbeld, Ron Hj Mathijssen, Jaap Verweij, et al.
International Journal of Cancer|February 13, 2004
Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancerWouter H de Vos tot Nederveen Cappel, Hielke J Meulenbeld, Jan H Kleibeuker, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2013
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)Hielke J Meulenbeld, Johann S de Bono, Scott T Tagawa, et al.
BJU International|August 30, 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failureHielke J Meulenbeld, Jean P Bleuse, Elio M Vinci, et al.
Cancers|August 23, 2019
Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with CabazitaxelIngeborg E de Kruijff, Anieta M Sieuwerts, Wendy Onstenk, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
European Urology|July 20, 2015
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor CellsWendy Onstenk, Anieta M Sieuwerts, Jaco Kraan, et al.
Pageof 1